Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Reem Elfeky, Arina Lazareva, Waseem Qasim & Paul Veys. (2019) Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources. Expert Review of Clinical Immunology 15:7, pages 735-751.
Read now
Read now
Articles from other publishers (20)
Geoffrey D. E. Cuvelier, Kristjan Paulson & Eric J. Bow. (2023) Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections. Transplant Infectious Disease 25:S1.
Crossref
Crossref
Jia Li, Yan Wang, Yuanfeng Zhang, Xiaoyu Zhang, Aiming Pang, Donglin Yang, Xin Chen, Rongli Zhang, Jialin Wei, Qiaoling Ma, Weihua Zhai, Yi He, Yizhou Zheng, Erlie Jiang, Mingzhe Han & Sizhou Feng. (2023) Haematopoietic stem cell transplantation for hepatitis‐associated aplastic anaemia and non‐hepatitis‐associated aplastic anaemia: A propensity score‐matched analysis. British Journal of Haematology 201:6, pages 1179-1191.
Crossref
Crossref
Yuhua Ru, Jinjin Zhu, Tiemei Song, Yiyang Ding, Ziling Zhu, Yi Fan, Yang Xu, Aining Sun, Huiying Qiu, Zhengming Jin, Xiaowen Tang, Yue Han, Chengcheng Fu, Suning Chen, Xiao Ma, Feng Chen, Jia Chen & Depei Wu. (2022) Features of Epstein–Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Ivan S. Moiseev, Elena V. Babenko, Olga S. Epifanovskaya, Vladislav S. Sergeev, Anna A. Dotcenko, Evgeny A. Bakin, Elena A. Surkova, Daria A. Kuznetsova, Sergey V. Lapin, Olga V. Pirogova, Alexandr L. Alyanskii, Alla A. Golovacheva, Elena I. Darskaya, Elena V. Morozova, Inna V. Markova, Sergey N. Bondarenko & Boris V. Afanasyev. (2019) High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide. Bone Marrow Transplantation 55:3, pages 544-552.
Crossref
Crossref
Xiao-Ning Gao, Ji Lin, Li-Jun Wang, Fei Li, Hong-Hua Li, Shu-Hong Wang, Wen-Rong Huang, Chun-Ji Gao, Li Yu & Dai-Hong Liu. (2019) Risk factors and clinical outcomes of Epstein–Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies. Annals of Hematology 98:9, pages 2163-2177.
Crossref
Crossref
L H Xie, M Biondo, S J Busfield, A Arruda, X Yang, G Vairo & M D Minden. (2017) CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission. Blood Cancer Journal 7:6, pages e567-e567.
Crossref
Crossref
Liwen Xu, Xiaoqing You, PingPing Zheng, Bing M. Zhang, Puja K. Gupta, Philip Lavori, Everett Meyer & James L. Zehnder. (2017) Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use. The Journal of Molecular Diagnostics 19:1, pages 72-83.
Crossref
Crossref
Evelyn Ullrich, Emilia Salzmann-Manrique, Shahrzad Bakhtiar, Melanie Bremm, Stephanie Gerstner, Eva Herrmann, Peter Bader, Petra Hoffmann, Ernst Holler, Matthias Edinger & Daniel Wolff. (2016) Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation. Frontiers in Immunology 7.
Crossref
Crossref
Rupert Handgretinger, Peter Lang & Maya C. André. (2016) Exploitation of natural killer cells for the treatment of acute leukemia. Blood 127:26, pages 3341-3349.
Crossref
Crossref
Ulas D. Bayraktar, Denái R. Milton, Michele Guindani, Gabriela Rondon, Julianne Chen, Gheath Al-Atrash, Katayoun Rezvani, Richard Champlin & Stefan O. Ciurea. (2016) Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation 22:3, pages 505-513.
Crossref
Crossref
Merav Bar & Mary E. D. Flowers. 2016. Transplant Infections. Transplant Infections
951
962
.
Caroline A. Lindemans, Liane C.J. te Boome, Rick Admiraal, Els C. Jol-van der Zijde, Anne M. Wensing, A. Birgitta Versluijs, Marc B. Bierings, Jürgen Kuball & Jaap J. Boelens. (2015) Sufficient Immunosuppression with Thymoglobulin Is Essential for a Successful Haplo-Myeloid Bridge in Haploidentical-Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 21:10, pages 1839-1845.
Crossref
Crossref
Amir A. Toor, Roy T. Sabo, Catherine H. Roberts, Bonny L. Moore, Salman R. Salman, Allison F. Scalora, May T. Aziz, Ali S. Shubar Ali, Charles E. Hall, Jeremy Meier, Radhika M. Thorn, Elaine Wang, Shiyu Song, Kristin Miller, Kathryn Rizzo, William B. Clark, John M. McCarty, Harold M. Chung, Masoud H. Manjili & Michael C. Neale. (2015) Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes. Biology of Blood and Marrow Transplantation 21:7, pages 1237-1245.
Crossref
Crossref
Fotios V. Michelis, Hans A. Messner, David Loach, Jieun Uhm, Vikas Gupta, Jeffrey H. Lipton, Matthew D. Seftel, John Kuruvilla & Dennis D. Kim. (2014) Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts. European Journal of Haematology 93:4, pages 273-280.
Crossref
Crossref
Jennifer M. Knight, Jeffrey M. Lyness, Olle Jane Z. Sahler, Jane L. Liesveld & Jan A. Moynihan. (2013) Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways. Psychoneuroendocrinology 38:11, pages 2383-2393.
Crossref
Crossref
L J DeCook, M Thoma, T Huneke, N D Johnson, R A Wiegand, M M Patnaik, M R Litzow, W J Hogan, L F Porrata & S G Holtan. (2012) Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning. Bone Marrow Transplantation 48:5, pages 708-714.
Crossref
Crossref
Pau Montesinos, Adriana Gascón, David Martínez-Cuadrón, María-Leonor Senent, Lourdes Cordón, Jaime Sanz, Amparo Sempere, María López-Pavía, Rebeca Rodríguez-Veiga, María J. Hurtado, Federico Gomis, Guillermo Martín, Ignacio Lorenzo, Javier Palau, María D. Planelles, Luis Larrea, Nelly Carpio, Mariluz Pérez-Sirvent, Miguel A. Sanz & Guillermo F. Sanz. (2012) Significance of Increased Blastic-Appearing Cells in Bone Marrow Following Myeloablative Unrelated Cord Blood Transplantation in Adult Patients. Biology of Blood and Marrow Transplantation 18:3, pages 388-395.
Crossref
Crossref
Mark H. Kirschbaum, Anthony S. Stein, Leslie Popplewell, Maria Delioukina, Robert Chen, Ryotaro Nakamura, David Snyder, Joel Conrad, Simon F. Lacey, Paul Frankel, Andrew Dagis, Auayporn Nademanee & Stephen J. Forman. (2012) A Phase I Study in Adults of Clofarabine Combined with High-Dose Melphalan as Reduced-Intensity Conditioning for Allogeneic Transplantation. Biology of Blood and Marrow Transplantation 18:3, pages 432-440.
Crossref
Crossref
Colleen M. O'Connor, Sabina Sheppard, Cassie A. Hartline, Helen Huls, Mark Johnson, Shana L. Palla, Sourindra Maiti, Wencai Ma, R. Eric Davis, Suzanne Craig, Dean A. Lee, Richard Champlin, Heather Wilson & Laurence J. N. Cooper. (2012) Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy. Scientific Reports 2:1.
Crossref
Crossref
Evelien L. J. Smits, Cindy Lee, Nicola Hardwick, Suzanne Brooks, Viggo F. I. Van Tendeloo, Kim Orchard & Barbara-ann Guinn. (2011) Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Cancer Immunology, Immunotherapy 60:6, pages 757-769.
Crossref
Crossref